Bowmed Ibisqus Limited
Registered name: BOWMED IBISQUS LIMITED
Part of Istituto Biochimico Italiano Giovanni Lorenzini S.P.A groupBowmed Ibisqus Limited made £32m revenue and £3.4m profit in the year to 31 Dec 2024.
Bowmed Ibisqus Limited’s revenue grew 21% to £32m in the year to 31 Dec 2024, with £3.4m profit and 11 employees. The company is classified under “wholesale of pharmaceutical goods” and is based in Manchester; we hold 3 years of its filed accounts.
- Status
- Active
- Location
- Manchester, North West
- Age
- 19 yrs · since 2007
- Type
- Private Limited Company
Part of a group. The filing indicates this company sits within a group structure, so its results may depend on intra-group trading and it may be hard to replicate independently. From the filing: “The immediate parent undertaking is Istituto Biochimico Italiano Giovanni Lorenzini S.p.A ("IBI SpA"), incorporated in Italy.The ultimate parent company is IBIGEN Srl, a company incorporated in Italy ”
Key figures
Badges are automated estimates derived from the filed figures — not statements of fact about the company.
Financial history
| Year to | 31 Dec 2022 | 31 Dec 2023 | 31 Dec 2024 |
|---|---|---|---|
| Disclosure | Full P&L | Full P&L | Full P&L |
| Profit & loss | |||
| Revenue (turnover) | £22.3m | £26.4m | £32m |
| Cost of sales | £17.9m | £21.1m | £24.7m |
| Gross profit | £4.4m | £5.3m | £7.3m |
| Operating profit | £2.7m | £3.5m | £4.6m |
| Profit after tax | £2.2m | £2.8m | £3.4m |
| Profit (best available) | £2.2m | £2.8m | £3.4m |
| Staff costs | £875k | £937k | £1.1m |
| Employees (average) | 9 | 10 | 11 |
| Ratios | |||
| Profit margin | 9.8% | 10.6% | 10.6% |
| Gross margin | 19.8% | 20.1% | 22.9% |
| Revenue per employee | £2.5m | £2.6m | £2.9m |
| Profit per employee | £243k | £280k | £308k |
| Cash conversion | −109.9% | 52.2% | −86.8% |
| Growth (year on year) | |||
| Revenue growth | — | ▲18.1% | ▲21.5% |
| Profit growth | — | ▲27.6% | ▲21.1% |
| Headcount growth | — | ▲11.1% | ▲10% |
| Balance sheet — indirect signals, not revenue | |||
| Cash at bank | £5.6m | £1.2m | £939k |
| Net assets | £8m | £8.5m | £8.9m |
| Current assets | £15.6m | £13.9m | £14.2m |
| Debtors | £4.1m | £3.6m | £5m |
| Cash from operations | −£3m | £1.8m | −£4m |
| Source | FullAccounts · bulk data Jul 2024 | FullAccounts · bulk data Jul 2024 | FullAccounts · bulk data Sep 2025 |
How the business works
- Profit margin
- 10.6%
- Profit ÷ revenue.
- Gross margin
- 22.9%
- Gross profit ÷ revenue. High for software and services.
- Revenue per employee
- £2.9m
- Revenue ÷ average employees.
- Profit per employee
- £308k
- Profit ÷ average employees.
- Cash conversion
- −86.8%
- Cash generated from operations ÷ operating profit. Needs a cash-flow statement.
- Fixed assets ÷ revenue
- —
- Capital intensity. Low = capital-light, cheaper to start.
- Deferred income ÷ revenue
- —
- Customers paying upfront (subscriptions, deposits). Approximate when combined with accruals.
- Debtors ÷ revenue
- 15.6%
- Money owed by customers. Low = customers pay quickly.
Balance-sheet signals
Year-on-year changes in filed balance-sheet items. They can hint at momentum (or investment) but are not revenue or profit and must not be read as such.
- Net assets
- ▲4%
- Now £8.9m
- Cash at bank
- ▼20%
- Now £939k
- Headcount
- ▲10%
- Now 11
- Deferred income
- —
- Now —
- Fixed assets
- —
- Now —
Group structure
Ownership chain
- Istituto Biochimico Italiano Giovanni Lorenzini S.P.A (registered outside the UK register)ultimate parent75–100%
- Bowmed Ibisqus Limitedthis company
Bands show the share of ownership each company holds in the one below it.
From the Persons with Significant Control register (corporate controllers only).
Similar profitable businesses
- Medreich PLCFeltham · Wholesale of pharmaceutical goods
- Revenue
- £32.7m
- Profit
- £440k
- Staff
- 32
- Paul Murray PLCSouthampton · Wholesale of pharmaceutical goods
- Revenue
- £32.9m
- Profit
- £1.7m
- Staff
- 92
- Ims Euro LimitedStockport · Wholesale of pharmaceutical goods
- Revenue
- £32.9m
- Profit
- £5.5m
- Staff
- 83
- Beta Pharmaceuticals LimitedWitham · Wholesale of pharmaceutical goods
- Revenue
- £34.3m
- Profit
- £120k
- Staff
- 61
- Adelphi (Tubes) LimitedHaywards Heath · Wholesale of pharmaceutical goods
- Revenue
- £29.6m
- Profit
- £8.7m
- Staff
- 31
- Greiner Bio-One LimitedStonehouse · Wholesale of pharmaceutical goods
- Revenue
- £29.3m
- Profit
- £958k
- Staff
- 39
Sources
Latest figures from FullAccounts for the year to 31 Dec 2024 (profit £3.4m), from the Companies House accounts bulk data published Sep 2025. Spotted an error? Request a correction.
Contains public sector information from Companies House licensed under the Open Government Licence v3.0. Data from Companies House, © Crown copyright. View the licence.